Genetic evidence for the involvement of different oxidative mechanisms in drug oxidation
暂无分享,去创建一个
[1] B. Cox,et al. Possible involvement of 5‐hydroxytryptamine in dopamine‐receptor‐mediated hypothermia in the rat , 1979, The Journal of pharmacy and pharmacology.
[2] J. Idle,et al. Polymorphism of carbon oxidation of drugs and clinical implications. , 1978, British medical journal.
[3] J. Idle,et al. POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN , 1977, The Lancet.
[4] J. Baty,et al. Acetaminophen production in man after coadministration of acetanilid and phenacetin; A study with stable isotopes , 1977, Clinical pharmacology and therapeutics.
[5] M. Eastwood,et al. Letter: Neutrophil function and myeloperoxidase activity in inflammatory bowel disease. , 1976, Lancet.
[6] B. Martin. Treatment of Data from Drug Urinary Excretion , 1967, Nature.
[7] A. Cummings,et al. A kinetic study of drug elimination: the excretion of paracetamol and its metabolites in man. , 1967, British journal of pharmacology and chemotherapy.
[8] J. W. COOK,et al. A Text-Book of Practical Organic Chemistry , 1948, Nature.
[9] J. Gaddum. THE PHARMACOLOGICAL BASIS OF THERAPEUTICS , 1941, Nature.